Predominance of Trypanosoma rangeli infection in children from a Chagas disease endemic area in the west-shore of the Panama canal

Memorias do Instituto Oswaldo Cruz

Volumn 100, Issue 7, 2005, Pages 729-731

  Saldaña, Azael ^a   Samudio, Franklyn ^a   Miranda, Aracelis ^a   Herrera, Lissette M ^a   Saavedra, Sara P ^a   Cáceres, Lorenzo ^a   Bayard, Vicente ^a   Calzada, José E ^a  

^a Malaria Drug and Vaccine Evaluation Center   (Panama)

Author keywords

Children infection; Panama; Trypanosoma rangeli

Indexed keywords

TRYPANOSOMA; TRYPANOSOMA CRUZI; TRYPANOSOMA RANGELI;

EID: 31544451278     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762005000700008     Document Type: Article

References (16)

1. Basso B, Cervetta L, Moretti E, Carlier Y, Truyens C 2004. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice. Vaccine 15-16: 1868-1872.
2. Chiurillo MA, Crisante G, Rojas A, Peralta A, Dias M, Guevara P, Anez N, Ramirez JL 2003. Detection of Trypanosoma cruzi and Trypanosoma rangeli infection by duplex PCR assay based on telomeric sequences. Clin Diagn Lab Immunol 10: 775-779.
3. Cuba Cuba A 1998. Review of the biologic and diagnostic aspects of Trypanosoma (Herpetosoma) rangeli. Rev Soc Bras Med Trop 31: 207-220.
4. Guhl F, Nicholls S 2001. Manual de Procedimientos para el Diagnóstico de la Enfermedad de Chagas, República de Colombia, Ministerio de Salud, Bogota, 98 pp.
5. Guhl F, Vallejo GA 2003. Trypanosoma (Herpetosoma) rangeli Tejera, 1920: an updated review. Mem Inst Oswaldo Cruz 98: 435-442.
6. Guhl F, Hudson L, Marinkelle CJ, Jaramillo CA, Bridge D 1987. Clinical Trypanosoma rangeli infection as a complication of Chagas' disease. Parasitology 94: 475-484.
7. Hudson L, Guhl F, de Sanchez N, Bridge D, Jaramillo CA, Young A 1988. Longitudinal studies of the immune response of Colombian patients infected with Trypanosoma cruzi and T. rangeli. Parasitology 96: 449-460.
8. Palau MT, Mejia AJ, Vergara U, Zuniga CA 2003. Action of Trypanosoma rangeli in infections with virulent Trypanosoma cruzi populations. Mem Inst Oswaldo Cruz 98: 543-548.
9. Romaña CA, Brunstein D, Collin-Delavaud A, Sousa O, Ortega-Barria E 2003. Public policies of development in Latin America and Chagas' disease. Lancet 16: 579.
10. Saldaña A, Sousa OE, Orn A 1995. Immunoparasitological studies of Trypanosoma cruzi low virulence clones from Panama: humoral immune responses and antigenic cross-reactions with Trypanosoma rangeli in experimentally infected mice. Scand J Immunol 42: 644-650.
11. Sousa OE, Johnson CM 1971. Frequency and distribution of Trypanosoma cruzi and Trypanosoma rangeli in the Republic of Panama. Am J Trop Med Hyg 20: 405-410.
12. Sousa OE, Johnson CM 1973. Prevalence of Trypanosoma cruzi and Trypanosoma rangeli in triatomines (Hemiptera: Reduviidae) collected in the Republic of Panama. Am J Trop Med Hyg 22: 18-23.
13. Sousa OE, Saldaña A 1994. Aspectos epidemiológicos y relaciones antigénicas entre tripanosomas en áreas de transmisión por Rhodnius pallescens. Rev Med-Cient AEM Panama 9: 16-24.
14. Vasquez AM, Samudio FE, Saldana A, Paz HM, Calzada JE 2004. Eco-epidemiological aspects of Trypanosoma cruzi, Trypanosoma rangeli, and their vector (Rhodnius pallescens) in Panama. Rev Inst Med Trop São Paulo 46: 217-222.
15. Vasquez JE, Krusnell J, Orn A, Sousa OE, Harris RA 1997. Serological diagnosis of Trypanosoma rangeli infected patients. A comparison of different methods and its implications for the diagnosis of Chagas' disease. Scand J Immunol 45: 322-330.
16. Zuñiga C, Palau T, Penin P, Gamallo C, de Diego JA 1997. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi. Trop Med Int Health 2: 482-487.